The antiviral activity of 9-beta-D-arabinofuranosyladenine (ARA-A).
D000225:Adenine / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006224:Cricetinae; D003561:Cytarabine / Q000627:therapeutic use; D004267:DNA Viruses; D003857:Deoxyuridine / Q000627:therapeutic use; D004660:Encephalitis / Q000188:drug therapy*; D007042:Hypoxanthines / Q000008:administration & dosage / Q000627:therapeutic use*; D007271:Injections, Intradermal; D007274:Injections, Intraperitoneal; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D051379:Mice; D009824:Ointments; D012328:RNA Viruses; D018139:Simplexvirus; D013882:Thiosemicarbazones / Q000627:therapeutic use; D014616:Vaccinia virus
D000998:Antiviral Agents; D007042:Hypoxanthines; D009824:Ointments; D013882:Thiosemicarbazones; D003561:Cytarabine; D000225:Adenine; D003857:Deoxyuridine